Company / Capital Expenditures
GRAIL, Inc. Capital Expenditures History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$909.0K
FY2025
5-year range
$909.0K / $22.9M
FY2022-FY2025
Trend
-82.5%
vs FY2024
Sector context
#147 of 151
Health Care
What the data says
Among 151 Health Care companies, GRAIL, Inc. is in the bottom 3% for capital expenditures. Capital Expenditures has declined for 3 consecutive years, from $23M in FY2022 to $909,000 in FY2025.
Based on SEC 10-K filings.
$909,000 in FY2025 with a 3-year CAGR of -65.9%.
Declined from $13M to $909,000 over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -65.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 151This company $909.0K Sector average $271.7M
▼
-99.7% below sector average
Key checks
Key Insights
- GRAIL, Inc.'s capital expenditures has declined for 3 consecutive years.
- 3-year CAGR of -65.9%, indicating a declining trend.
- In FY2025, capital expenditures decreased 82.5% year-over-year.
- Ranks #147 out of 151 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $909.0K | -82.5% |
| FY2024 | $5.2M | -59.6% |
| FY2023 | $12.9M | -43.6% |
| FY2022 | $22.9M | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026